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AIMS AND OBJECTIVES 
AIM 
To test the hypothesis that abnormal central venous oxygen saturation (ScvO2) is associated 
with high mortality in patients with sepsis and polytrauma. 
 
OBJECTIVES 
1) To assess the effect of abnormal (low and supranormal) central venous oxygen saturation 
(ScvO2) and incidence of morbidity and mortality in the population who are admitted with 
the diagnosis of sepsis and polytrauma to our surgical ICU. 
2) To explore the relationship between abnormal (low and supranormal) central venous 
oxygen saturation (ScvO2) and lactates with outcome of SICU admission among sepsis and 
polytrauma patients. 
3) To estimate the correlation between central venous oxygen saturation (ScvO2) and the 
following 
• APACHE II score 
• Duration of ICU stay 
• Length of ventilated days and inotropic support 
• Coagulopathy and dialysis requirement 
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ABSTRACT 
TITLE  : A prospective observational study to characterize the association of abnormal 
central venous oxygen saturation to the morbidity and mortality in patients admitted to the 
surgical intensive Care unit with a diagnosis of sepsis or polytrauma. 
DEPARTMENT- ANAESTHESIA 
NAME OF CANDIDATE- JYOTHI AVULA 
DEGREE AND SUBJECT- MD ANAESTHESIA 
NAME OF THE GUIDE- DR K SUBRAMANI 
                                        ASSOCIATE PROFESSOR 
                                        DEPARTMENT OF ANAESTHESIA 
                                         CMC VELLORE 
OBJECTIVES -        Abnormal (low and supranormal) central venous oxygen saturation 
(ScvO2) with associated hyperlactatemia has been shown to be associated with increased 
mortality in post-operative cardiac surgery patients and in patients with sepsis. We want to 
assess the effect of these and incidence of morbidity and mortality in the population who are 
admitted with a diagnosis of sepsis and poly trauma to our surgical ICU.  
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METHODS –   A prospective observational study was done in all patients who met the 
inclusion criteria and had a diagnosis of sepsis and polytrauma.  They were assessed during 
initial 6 hours and their SCV02 was measured at admission and 6 hours later and its 
association to mortality and other variables like lactates and base excess and duration of icu 
stay and inotropic support were assessed and analysed using a multivariate model analysis. 
RESULTS -    When compared to the normal group, the hyperoxia group had a risk ratio  
of 2.422 times more likelihood of mortality and the hypoxia group had 1.0256 times more 
likelihood of mortality. When the hypoxia group was compared with the hyperoxia group the 
risk ratio for mortality was 2.36 times more in the hyperoxia group though the p value was 
not significant. 
There was no statistically significant difference between the 3 groups of Scv02 when 
compared to duration of icu stay, duration of inotropic support and coagulopathy and need for 
dialysis and apache11 score and base excess and lactates. 
 
CONCLUSIONS –    When lactates, base excess and Scv02 were compared to mortality 
though not significant; gave a j shaped curve suggesting that mortality is higher both in the 
hypoxia and the hyperoxia group compared to the normoxia group. The small sample size 
though was adequate to predict a trend, was insufficient to address secondary objectives. 
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INTRODUCTION 
Sepsis and trauma are major causes of mortality and morbidity in ICU patients. The common 
feature in these two conditions is systemic inflammation and deranged oxygen delivery. 
Unfortunately, until recently, numerous therapies to treat sepsis failed to improve mortality. 
The three main resuscitation targets are preload (measured by central venous pressure), 
perfusion (mean arterial pressure), and tissue hypoxia (base excess and blood lactate). The 
Early Goal Directed therapy (EGDT) trial in septic patients whose haemodynamic parameters 
were optimized within the first 6 hours after hospital admission showed an improved 
outcome. The trial demonstrated that optimization oxygen delivery by optimizing central 
venous oxygen saturation and mean arterial blood pressure improved outcome. Central 
venous oxygen saturation is obtained by measuring the oxygen saturation in venous blood 
returning to the heart. In simple form, it represents the balance between oxygen delivery and 
oxygen consumption which is an indication of oxygen extraction. In sepsis and trauma, 
oxygenation of blood in the lungs, delivery of oxygenated blood to the tissues, and utilization 
of oxygen by various tissues are affected by various mechanisms. Early Identification and 
treatment of this imbalance in oxygen delivery and utilization will prevent organ failure and 
reduce morbidity and mortality in the ICU patients.(1) 
                               
Thus, a low ScvO2 may indicate a decrease in systemic oxygen delivery, an increase 
in oxygen extraction or a combination of the two. In the EGDT protocol, a low ScvO2 is 
addressed through oxygen delivery optimization by improving arterial oxygen saturation, 
cardiac output, or oxygen carrying capacity to increase oxygen delivery. Accordingly, one 
may broadly categorize deficiencies in oxygen exchange into three types of failure: 1) macro 
circulatory failure, 2) microcirculatory failure, and 3) mitochondrial failure. Macro 
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circulatory failure is typically assessed through parameters such as central venous pressure 
(CVP), mean arterial pressure (MAP) and cardiac output. A reduction in any of these 
parameters can result in an inadequacy in the net amount of oxygen delivered to the tissues. 
The cause of microcirculatory failure is multi factorial and includes physiologic shunting, 
maldistributed flow, increased micro vascular permeability, and micro vascular thrombosis. 
In some instances, there may be adequate macro circulatory flow but microcirculatory failure 
prevents the oxygen from reaching tissues. Finally, in mitochondrial failure, oxygen is 
presented to the cell but the mitochondria are dysfunctional and unable to process the oxygen. 
In the latter two cases, the ScvO2 may actually be elevated-a condition referred to as tissue 
dysoxia.(2) 
 
                                         The clinical impacts of abnormally low and high ScvO2 values in 
patients who receive the same protocol are not well characterized. The notion of abnormally 
elevated ScvO2 levels representing hypoxia at the cellular level has been reported but there is 
little evidence in support of its clinical significance. Furthermore, since the EGDT-based 
protocol aims to correct a low ScvO2 level through a titrated resuscitation, it is not clear 
whether the initial ScvO2 level and/or the maximum ScvO2 achieved have an association with 
mortality. In a study done both low (60.8%) and supranormal (77.4%) ScvO2 were associated 
with an unfavourable course. 
 
                        Patients with low ScvO2 and an uneventful course initially presented with 
normal lactate levels, whereas patients with supra normal ScvO2 displayed consistently 
higher serum lactate levels. High ScvO2 values were associated with the signs of systemic 
inflammation. Mortality rates in the patient groups presenting either low (14.8%) or supra 
normal ScvO2 (7.9%) and higher than normal (0%). This was significant (p< 0.001). Blood 
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Lactate was increased in patients who ultimately died, irrespective whether they had low or 
supra normal ScvO2 values.  High ScvO2 is an under-recognized warning sign for impaired 
tissue oxygenation in patients with sepsis. 
Supra normal values of ScvO2, which are traditionally considered to be of limited 
clinical value, turned out to be under-recognized warning signs of impaired tissue 
oxygenation in cardiac surgery patients. The study group have proposed that combined 
analysis of ScvO2 and lactate levels may be used to identify patients at risk, and a high 
ScvO2 might reflect an under recognized warning sign. In this context, additional studies are 
warranted to test these results in other groups of acutely ill patients.(3) 
     ScVO2 monitoring can be an early indicator of bleeding, estimated blood loss, and may 
affect the decision to transfuse. In a study of 26 trauma patients, Scalea and colleagues found 
that the 10 patients who had ScVO2 less than 65% had more serious injuries, significantly 
larger estimated that losses, and required more transfusions than those patients with ScVO2 
greater than 65%. In this study linear regression coefficients showed that ScVO2 was better 
than heart rate, MAP, CVP, pulse pressure, and urine output in predicting estimated blood 
loss. 
 
Global tissue hypoxia is one of the most important factors in the development of MODS. In 
hemodynamically unstable critically ill patients, superior venacaval oxygen saturation 
(ScVO2) and mixed venous saturation (SVO2) monitoring has been shown to be a better 
indicator of global tissue hypoxia than vital signs and other clinical parameters alone. ScVO2 
monitoring can have diagnostic and therapeutic uses in understanding the efficacy of 
interventions in treating critically ill, hemodynamically unstable patients.(4) 
 In this prospective observational study, we aimed to characterize the association of abnormal 
(low and supranormal) central venous oxygen saturation (ScvO2) to the course and mortality 
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in patients admitted to surgical intensive care unit with a diagnosis of sepsis and trauma. Our 
aim is to test the hypothesis that abnormal ScvO2 is associated with high mortality in patients 
with sepsis and polytrauma.(5)(6) 
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LITERATURE REVIEW 
INTRODUCTION TO SEPSIS 
Sepsis and septic shock are as common and lethal as any other acute lethal conditions that 
any physician routinely confront such as myocardial infarction, stroke and trauma. 
The story of sepsis over the past 100 years has been a fascinating tale of discovery.  Great 
strides have been made in terms of understanding the extra and intracellular events that 
contribute to organ system dysfunction.  There has also been progress in management, with 
several studies suggesting reduced mortality rates as a result of improved supportive and 
pharmacologic management of these critically ill patients. Widely publicized evidence-based 
guidelines have been published to help the clinician manage the patient with severe sepsis.  
However, mortality rates still remain unacceptably high (30-50%) and it is apparent that 
much remains to be done to advance our understanding and treatment of this common 
condition.(7) 
The systemic inflammatory syndrome can be self-limited or can progress to severe sepsis and 
septic shock.  These are conditions with mortality rates approaching up to fifty percent.   The 
normal host response to infection is a complex process that localises and controls invasion 
and initiates repair of injured tissues, a process during which there is activation of several 
inflammatory mediators. Severe sepsis results when the host response to infection becomes 
generalised involving tissues remote from site of injury.(8) 
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DEFINITIONS 
Sepsis is defined as the presence or presumed presence of an infection accompanied by 
evidence of a systemic response called the systemic inflammatory response syndrome 
(SIRS).(9) 
 
Systemic inflammatory response syndrome is defined as the presence of 2 or more of the 
following: 
(1) Temperature greater than 38°C (100.4°F) or less than 36°C (96.8°F); 
(2) Pulse rate greater than 90 beats/min. 
(3) Respiratory rate greater than 20 breaths/min (or PaCO2 less than 32 mm Hg) 
(4) WBC count greater than 12,000/mm3 or less than 4,000/mm3, or greater than 10%       
immature cells (band forms).(8) 
 
The new definition, although more comprehensive than systemic inflammatory response 
syndrome, is vague in its requirement of some of the many clinical and laboratory findings in 
addition to suspicion of infection.  By definition, sepsis describes only the presumed 
existence of an infection and at least a minimal systemic response and therefore would not 
necessarily imply the existence of hemodynamic compromise or a bacterial cause, as is often 
suggested. 
Septic shock can be viewed as severe sepsis with cardiovascular failure (organ perfusion). 
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Definitions of systemic inflammatory response syndrome (SIRS) and 
different degrees of severity of sepsis(8) 
 
Condition Description 
 
Systemic 
inflammatory 
response 
syndrome 
 
Two or more of the following conditions: temperature >38.5°C or 
<35.0°C; heart rate of >90 beats/min; respiratory rate of >20 
breaths/min or PaCO2 of <32 mm Hg; and WBC count of >12,000 
cells/mL, <4000 cells/mL, or >10 percent immature (band) forms 
 
Sepsis 
 
SIRS in response to documented infection (culture or Gram stain of 
blood, sputum, urine, or normally sterile body fluid positive for 
pathogenic microorganism; or focus of infection identified by visual 
inspection, e.g., ruptured bowel with free air or bowel contents found in 
abdomen at surgery, wound with purulent discharge) 
 
 
Severe sepsis 
 
 
Sepsis and at least one of the following signs of organ hypoperfusion or 
organ dysfunction: areas of mottled skin; capillary refilling of ≥3 s; 
urinary output of <0.5 mL/kg for at least 1 h or renal replacement 
therapy; lactate >2 mmol/L; abrupt change in mental status or abnormal 
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EEG findings; platelet count of <100,000 cells/mL or disseminated 
intravascular coagulation; acute lung injury or ARDS; and cardiac 
dysfunction (echocardiography) 
 
 
Septic shock 
 
 
 
Severe sepsis and one of the following conditions: systemic mean BP of 
<60 mm Hg (<80 mm Hg if previous hypertension) after 20 to 30 mL/kg 
starch or 40 to 60 mL/kg saline solution, or PCWP between 12 and 20 
mm Hg; and need for dopamine of >5 mcg/kg/min, or norepinephrine or 
epinephrine of <0.25 mcg/kg/min to maintain mean BP at >60 mm Hg 
(80 mm Hg if previous hypertension) 
 
 
Refractory 
septic shock 
 
 
Need for dopamine at >15 mcg/kg/min, or norepinephrine or 
epinephrine at >0.25 mcg/kg/min to maintain mean BP at >60 mm Hg 
(80 mm Hg if previous hypertension) 
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EPIDEMIOLOGY 
Approximate incidence of severe sepsis from existing data is three per thousand persons per 
year, and of those 50% - 70%  need intensive care treatment with an overall hospital 
mortality of 30% - 50%.  The incidence increases exponentially with age suggesting the 
number of cases will increase in coming years as the population grows older.(7)(8) 
Till 2003 it was the same ICD (international classification of diseases)code for all definitions 
of sepsis.  Now severe sepsis and septic shock have separate code under the ICD 9.  This was 
proposed to distinguish high-risk patients from patients with sepsis.(8) 
Recent estimates indicate that the rate of severe sepsis hospitalizations doubled during the 
last decade and that age-adjusted population-based mortality is increasing. 
 
 
PATHOPHYSIOLOGY 
A series of pathogenic events are responsible for the  transition from sepsis to severe sepsis or 
septic shock.  The initial reaction to infection is a neurohumoral, generalized pro- and anti-
inflammatory response.  This begins with a cellular activation of monocytes, macrophages, 
and neutrophils that interact with endothelial cells through numerous pathogen recognition 
receptors.   A further host response includes the mobilization of plasma factors as a result of 
this cellular activation and endothelial disruption.  These plasma factors include cytokines 
such as tumour necrosis factor, interleukins, caspase, proteases, leukotriene’s, kinins, reactive 
oxygen species, nitric oxide, arachidonic acid, platelet activating factor, and eicosanoids.  
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Activation of the complement and coagulation cascades further amplifies this elaborate chain 
of events.  The vascular endothelium is the predominant site of these interactions, and, as a 
result, there is microvascular injury, thrombosis, and a loss of endothelial integrity (capillary 
leak), resulting in tissue ischemia.  This diffuse  endothelial disruption is responsible for the 
various organ dysfunctions and global tissue hypoxia that accompany severe sepsis or septic 
shock .  Key therapies that have led to mortality benefits in severe sepsis or septic shock are 
directed at reversing these pathogenic mechanisms.(8) 
 
STEPS IN PATHOPHYSIOLOGY OF SEPSIS 
Normal response of host to infection 
Initially there is binding of immune cell surface receptors like pattern recognition  receptors 
(PRRS) and triggering receptors expressed on myeloid cells(TREM-1) and myeloid –DAP12- 
associating lectin(MDL1) to the microbial components.   This has multiple effects  including 
activation of host inflammatory response, the pro-inflammatory mediators(TNF A  and IL1) 
which leads to recruitment of more polymorphonuclear leucocytes(PMN’s) and  macrophages 
and anti-inflammatory mediators(CYTOKINES).   If these mediators balance  each other and 
the initial infectious insult is overcome, homeostasis will be restored, the end  result being 
tissue repair and healing.(8) 
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Transition to sepsis 
Sepsis occurs when the release of proinflammatory mediators in response to either infectious 
or non-infectious conditions exceeds the boundaries of local environment leading to a more 
generalised response.  Sepsis can be conceptualised as a malignant intravascular 
inflammation as it is uncontrolled, unregulated , self-sustained and spreads via blood and is 
an exaggeration of normal inflammatory response. 
The cause is likely multifactorial and may include : 
• Direct effects of endotoxins released by the micro-organisms 
• Excess pro-inflammatory mediators 
• Complement activation 
• Genetic susceptibility (SNP-single nucleotide polymorphs) 
 
Systemic effects of sepsis 
Widespread cellular injury may occur when the immune response becomes generalized. 
Cellular injury is the precursor to organ dysfunction.  The precise mechanism of cellular 
injury is not understood, but its occurrence is indisputable as autopsy studies have shown 
widespread endothelial and parenchymal cell injury. 
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Mechanisms proposed to explain the cellular injury include: 
Tissue ischemia (insufficient oxygen relative to oxygen need),   cytopathic injury (direct cell 
injury by proinflammatory mediators and or other products of inflammation), and an altered 
rate of apoptosis (programmed cell death). 
Tissue hypoperfusion can be present even in the presence of normal blood pressure and 
adequate cardiac output, a state sometimes called as cryptic shock.  This may be due to  
preferential maldistribution of blood flow at the microvascular level or related to 
mitochondrial dysfunction in the presence of adequate substrate delivery. 
 
Tissue ischaemia 
Significant derangement in metabolic autoregulation, the process that matches oxygen 
availability to changing tissue oxygen needs, is typical of sepsis.  Microcirculatory lesions 
may be the result of imbalances in the coagulation and fibrinolytic systems, both of which are 
activated during sepsis. 
Endothelial lesions may be a consequence of interactions between endothelial cells and 
activated polymorphonuclear leukocytes (PMNs).  The increase in receptor-mediated 
neutrophil-endothelial cell adherence induces the secretion of reactive oxygen species, lytic 
enzymes, and vasoactive substances (nitric oxide, endothelin, platelet-derived growth factor, 
and platelet activating factor) into the extracellular milieu, which may injure the endothelial 
cells. 
 
  21
Cytopathic injury 
Proinflammatory mediators and other products of inflammation may cause sepsis-induced 
mitochondrial dysfunction (e.g., impaired mitochondrial electron transport) via a variety of 
mechanisms, including direct inhibition of respiratory enzyme complexes, oxidative stress 
damage, and mitochondrial DNA breakdown .  Such mitochondrial injury leads to 
cytotoxicity.(10) 
The clinical relevance of mitochondrial dysfunction in septic shock was suggested by a study 
of 28 critically ill septic patients who underwent skeletal muscle biopsy within 24 hours of 
admission to the ICU .   Skeletal muscle ATP concentrations, a marker of mitochondrial 
oxidative phosphorylation, were significantly lower in the 12 patients who died of sepsis than 
in 16 survivors.  In addition, there was an association between nitric oxide overproduction, 
antioxidant depletion, and severity of clinical outcome.  Thus, cell injury and death in sepsis 
may be explained by cytopathic (or histotoxic) anoxia, which is an inability to utilize oxygen 
even when present.(10) 
 
Apoptosis 
During sepsis, proinflammatory cytokines may delay apoptosis in activated macrophages and 
neutrophils, thereby prolonging or augmenting the inflammatory response and contributing to 
the development of multiple organ failure. Sepsis also induces extensive lymphocyte and 
dendritic cell apoptosis, which alters the immune response efficacy and results in decreased 
clearance of invading microorganisms.  Apoptosis of lymphocytes has been observed at 
autopsies in both animal and human sepsis. The extent of lymphocyte  apoptosis correlates 
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with and the severity of the septic syndrome and the level of immunosuppression. Apoptosis 
has been also observed in parenchymal cells, endothelial, and epithelial cells. Several 
experimental studies show that inhibiting apoptosis protects  from organ dysfunction and 
lethality.(8) 
 
Organ specific effects of sepsis 
No organ system is spared from the consequences of sepsis, leading to multiorgan 
dysfunction.  The most common organ being affected is the circulatory system. 
Circulation 
Hypotension due to diffuse vasodilation is the most severe expression of circulatory 
dysfunction in sepsis.  It is probably an unintended consequence of the release of vasoactive 
mediators, whose purpose is to improve metabolic autoregulation (the process that matches 
oxygen availability to changing tissue oxygen needs) by inducing appropriate vasodilation. 
Mediators include  vasodilators like prostacyclin and nitric oxide , which are produced by 
endothelial cells.(8) 
Nitric oxide (NO) is believed to play a central role in the vasodilation accompanying septic 
shock. Inducible NO synthase can be induced by incubating vascular endothelium and 
smooth muscle with endotoxin.  When NO reaches the systemic circulation, it depresses 
metabolic autoregulation at all of the central, regional, and microregional levels of the 
circulation. In addition, NO may trigger an injury in the central nervous system that is 
localized to areas that regulate autonomic control.  Another factor that may contribute to the 
  23
persistence of vasodilation during sepsis is impaired compensatory secretion of antidiuretic 
hormone (ADH).(11) 
In addition to the diffuse effects on circulation, there are also localised effects.  In the central 
circulation (i.e., heart and large vessels), decreased systolic and diastolic ventricular 
performance due to the release of myocardial depressant substances is an early manifestation 
of sepsis.  In the regional circulation (i.e., small vessels leading to and within the organs), 
vascular hypo responsiveness (i.e., inability to appropriately vasoconstrict) leads to an 
inability to appropriately distribute systemic blood flow among organ systems. As an 
example, sepsis interferes with the redistribution of blood flow from the splanchnic organs to 
the core organs (heart and brain) when oxygen delivery is depressed.(11) 
The microcirculation (i.e., capillaries) may be the most important target in sepsis. Sepsis is 
associated with a decrease in the number of functional capillaries, which causes an inability 
to extract oxygen maximally. 
At the level of the endothelium, sepsis induces phenotypic changes to endothelial cells. This 
occurs through direct and indirect interactions between the endothelial cells and components 
of the bacterial wall. 
In the lung Endothelial injury in the pulmonary vasculature during sepsis disturbs capillary 
blood flow and enhances microvascular permeability, resulting in interstitial and alveolar 
pulmonary edema.  This creates ventilation-perfusion mismatch and leads to hypoxemia. 
Such lung injury is prominent during sepsis, likely reflecting the lung's large microvascular 
surface area. Acute respiratory distress syndrome is a manifestation of these effects. 
The other effects seen are liver dysfunction, acute renal failure, and CNS complications 
including altered sensorium and peripheral neuropathy. 
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Table1 -  
Biologic effects of proinflammatory cytokines such as 
TNF and IL‐1(8) 
Fever 
Hypotension 
Acute phase protein response 
Induction of IL‐6 and IL‐8 
Coagulation activation 
Fibrinolytic activation 
Leucocytosis 
Neutrophil degranulation and augmented antigen expression (TNF) 
Increased endothelial permeability (TNF) 
Stress hormone response 
Enhanced gluconeogenesis (TNF) 
 
 
Figure 1 ‐ Potential outcomes of mediator release in sepsis 
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Decreased oxygen extraction in sepsis  
Figure 2 
 
 
 
Physiology of Systemic Oxygen Transport and Utilization 
Because microvascular injury leads to decreased oxygen delivery and consumption at the cell 
and tissue level, the principles of oxygen transport physiology become requisite to an 
understanding of the pathogenic, diagnostic, and therapeutic implications of global tissue 
hypoxia. Oxygen is delivered to the tissues as a product of cardiac output and oxygen content 
(which is a product of haemoglobin oxygen saturation and haemoglobin).  
After oxygen is extracted at the tissue level, the remainder returns to the venous circulation. 
The product of Systemic oxygen delivery and the percentage of oxygen extracted (normally 
25%) by the tissues is the systemic oxygen consumption. The balance between systemic 
oxygen delivery and consumption is reflected by the mixed venous haemoglobin oxygen 
saturation (SvO2). Global tissue hypoxia results when there is an inability of systemic oxygen 
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delivery to meet the oxygen requirements of the tissues and results in lactic 
acidosis.(12)
figure.3    Oxygen transport 
 
One of the most important events leading to morbidity and mortality in patients with sepsis is 
the development of cardiovascular insufficiency and resulting global tissue hypoxia.  Global 
tissue hypoxia (or oxygen deprivation), which can occur before the development of 
hypotension, results in further endothelial activation and generalized inflammation.  Global 
tissue hypoxia develops from multiple mechanisms of cardiovascular insufficiency. These 
mechanisms include decreased preload, vasoregulatory dysfunction, myocardial depression, 
increased metabolic demands, and impaired tissue oxygen use resulting from 
microcirculatory dysfunction and cytopathic hypoxia.(12)(8) 
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First, although sepsis is commonly characterized as hyper dynamic, some patients may 
present in the early stages with a decreased preload because of concomitant left ventricular 
dysfunction and hypovolemia.   After fluid resuscitation to normalize filling pressures, 
compensatory mechanisms of ventricular dilatation and tachycardia permit a transition to a 
hyper dynamic state or high cardiac output. 
Second, even in the presence of a normal or high cardiac output in severe sepsis or septic 
shock, hypoperfusion abnormalities can still exist. This “distributive shock” refers to a state 
of either systemic or regional hypoperfusion as a result of derangements in blood flow 
distribution and loss of vasoregulatory control to the vascular beds. 
Third, myocardial depression reflecting a hypodynamic state with low cardiac output, thought 
to occur as a result of effects of inflammatory mediators, can be the predominant 
hemodynamic feature in up to 15% of patients presenting with severe sepsis or septic shock 
and may be especially profound in patients with pre-existing cardiac disease. 
Fourth, the inflammatory response accompanying sepsis is also associated with increased 
metabolic demands, reflected by an increase in splanchnic and total body oxygen 
consumption.  The combination of measuring central venous oxygen saturation (ScvO2), 
which is usually 5% to 7% higher than SvO2 with very good correlation coefficients, and 
lactate during initial patient assessment allows for the early recognition of these contributors 
to cardiovascular insufficiency and global tissue hypoxia that can occur despite the presence 
of stable vital signs. 
Last, in addition to sepsis causing impairment in oxygen delivery, the bioenergetics of 
cellular oxygen extraction and use or respiration may also be impaired.  This cytopathic 
hypoxia can manifest with a normal or high SvO2 and lactic acidosis. These derangements 
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further contribute to the cardiovascular insufficiency and may occur independent of 
hemodynamic parameters, such as arterial blood pressure.(8)(12) 
DIAGNOSIS 
To diagnose severe sepsis or septic shock as early as  possible, it is necessary to recognise 
historical, clinical, and laboratory findings that are indicative of infection, organ dysfunction 
and global tissue hypoxia. 
Infection, documented or suspected, and some of the following: 
General variables 
• Fever (core temperature 38.3°C [101.0°F]) 
• Hypothermia (core temperature 36°C [96.8°F]) 
• Pulse rate 90 beats/min or 2 SD above the normal value for age 
• Tachypnea (respiratory rate 20 breaths/min) 
• Altered mental status 
• Significant edema or positive fluid balance (20 mL/kg during 24 h) 
• Hyperglycaemia (plasma glucose 120 mg/dL or 7.7 mmol/L) in the absence of 
diabetes 
Inflammatory variables 
• Leucocytosis (WBC count 12,000/mm3) 
• Leukopenia (WBC count 4,000/mm3) 
• Normal WBC count with 10% immature forms 
• Plasma C-reactive protein 2 SD above the normal value 
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• Plasma procalcitonin 2 SD above the normal value 
Hemodynamic variables 
• Arterial hypotension (SBP 90 mm Hg, MAP 70 mm Hg, or an SBP decrease 40 mm 
Hg in adults or 2 SD below normal for age) 
• SvO2 < 70% 
• Cardiac index of <3.5 L/min/m2 
Organ dysfunction variables 
• Arterial hypoxemia (PaO2/FIO2 <300) 
• Acute oliguria (urine output 0.5 mL/kg/h for at least 2 h) 
• Creatinine increase 0.5 mg/dL 
• Coagulation abnormalities (INR 1.5 or aPTT 60 s) 
• Ileus (absent bowel sounds) 
• Thrombocytopenia (platelet count 100,000/mL) 
• Hyperbilirubinemia (plasma total bilirubin 4 mg/dL or 70 mmol/L) 
Tissue perfusion variables 
• Hyperlactatemia (2 mmol/L) 
• Decreased capillary refill or mottling 
 
SvO2 can be low (70%) in early sepsis, signifying inadequate oxygen delivery and global 
hypoperfusion. ScvO2 has been used as a surrogate of SvO2.  Hyperlactatemia is not always 
  30
accompanied by a low bicarbonate level or increased anion gap, and, thus, the lactate level 
must also be measured if severe sepsis is suspected.  Increased lactate levels among patients 
admitted to the hospital with infection and upward trends in lactate levels are associated with 
poor prognosis and may be used to guide response to therapy.   
The finding of an elevated serum lactate level (>4 mmol/L), even in the context of normal 
macrocirculatory markers of perfusion (i.e., cryptic shock), carries a worse prognosis and 
higher mortality than does a normal (<2 mmol/L) serum lactate level. In these situations, 
hyperlactemia indicates on-going tissue hypoperfusion due to misdistribution of flow in the 
microcirculation even after resuscitation and normalization of the macrocirculation.(13) 
 
EARLY HEMODYNAMIC OPTIMISATION 
A goal-directed hemodynamic resuscitation of severe sepsis or septic shock includes a 
systematic approach to restoration of systemic oxygen delivery through a manipulation of 
preload (volume), afterload (blood pressure), and contractility (stroke volume) to preserve 
effective tissue perfusion while avoiding excessive increases in myocardial oxygen 
consumption (i.e., tachycardia) and maintaining coronary perfusion pressure. 
Recently, a trial of early hemodynamic resuscitation to normal physiologic parameters, or 
early goal-directed therapy, was conducted in ED patients with severe sepsis or septic shock 
and revealed a significant mortality reduction.  Early goal-directed therapy is an algorithmic 
approach to hemodynamic optimization and resolution of global tissue hypoxia within the 
first 6 hours of disease presentation.  The strategy targets normal oxygen delivery by 
optimizing preload, afterload, oxygen content, and contractility to achieve a balance between 
tissue oxygen delivery and consumption (guided by central venous pressure, mean arterial 
  31
pressure, and ScvO2 monitoring).   Specifically, patients are treated by fluid resuscitation 
with either crystalloid or colloid to achieve a central venous pressure goal of 8 to 12 mm Hg, 
vasoactive agents to achieve a mean arterial pressure goal of 65 to 90 mm Hg,  blood 
transfusion to a hematocrit level greater than 30%,  inotrope therapy, and  intubation, 
sedation, and paralysis as necessary to achieve a ScvO2 of greater than 70% as measured by 
continuous central venous oxygen saturation monitoring.(12)(8) 
Rivers et al  examined efficacy of early goal-directed therapy in 263 patients with infection 
associated with hypotension after a fluid bolus or serum lactate level greater than or equal to 
4 mmol/L who were randomly assigned to receive standard resuscitation or early goal-
directed therapy (133 control versus 130 early goal-directed therapy) in the emergency 
department before ICU transfer.(14)(15)(16) 
The specific procedures to institute early goal directed therapy are the following. 
1) Hemodynamic monitoring 
2) Volume therapy 
3) Vasoactive agents 
4) Increasing oxygen carrying capacity 
5) Inotropic therapy 
6) Decreasing oxygen consumption 
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FLOW CHART FOR THE EARLY GOAL DIRECTED THERAPY FOR THE EARLY 
RESUSCITATION Of PATIENTS WITH SEVERE SEPSIS AND SEPTIC SHOCK(12) 
 
Figure 4 
 
Resuscitation end point s 
Trends of vital signs are not sufficient endpoints to determine an adequate response to 
therapy. Rady et al showed that 31 of 36 patients presenting with shock and resuscitated to 
normal vital signs continued to have global tissue hypoxia, as evidenced by decreased ScvO2 
and increased lactate levels.  A post hoc analysis of the early goal-directed therapy study in 
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patients with mean arterial pressure greater than 100 mm Hg showed that control patients 
with persistently abnormal ScvO2 and lactate levels at 6 hours had a significantly higher 
mortality rate compared with the early goal-directed therapy patients whose values had 
reached therapeutic goals (60.9% versus 20.0%, P.05).  Other studies have also showed that a 
persistently high lactate is associated with increased mortality.  Therefore, continuous ScvO2 
and serial lactate measurements during resuscitation may help identify patients requiring 
continued intensive therapy.(17)(8) 
 
MICROCIRCULATION 
The micro-circulation is endowed with certain peculiar characteristics.  First and foremost, 
the microcirculation is heterogenous with regard to rheologic and resistive properties in 
various organs and within the organ itself  . Heterogeneity of flow helps to supply adequate 
oxygen to tissues based on their metabolic demands. However, it also leads to 
microcirculatory units with unfavourable rheologic and or resistive properties, making  them 
weaker and thus more vulnerable to damage by hypoxia as encountered during sepsis. 
Secondly, in almost all vascular beds, there is a longitudinal and radial oxygen gradient such 
that the capillary pO 2 and haemoglobin saturation are significantly lower than arterial 
values.  
This results from oxygen unloading from arterial network to tissues, and the intrinsic oxygen 
consumption of vessel wall to sustain endothelial functions and vascular tone. These 
properties again make the exchange segment more prone to hypoxic damage. The 
microvascular haematocrit is lower than the systemic haematocrit, and is also 
heterogeneously distributed .  This decrease is due to the Fahreus effect that induces axial 
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migration of erythrocytes near the centre of vessels, resulting in differential erythrocyte and 
plasma velocities, and a dynamic decrease in intravascular haematocrit. The end result of all 
the above characteristics is a heterogeneity of blood flow and oxygen delivery in the 
microcirculation, resulting in vulnerable units prone to hypoxic damage.(11)(18) (19) 
 
Pathophysiology of microcirculation in sepsis 
 
                      The inflammatory mediators that herald sepsis, and the changes they induce in 
the macrohaemodynamics i.e., blood pressure, heart rate and oxygen extraction are well  
known. These are the changes induced in the microcirculation by sepsis.  "Five to fifteen 
minutes after its (endotoxin) intravenous administration, there were strong waves of con-
traction along the small arteries, arterioles, and metaarterioles. These could arrest flow and 
last for several minutes. There would afterwards be a phase of dilation, followed by a strong 
contraction. As time went on, the phases of relaxation became more prominent until  
preagonally there was a general and permanent vasodilation. The circulation would slow 
progress until death." This early description of response of microvessels to endotoxin in 
guinea pig and mouse mesentery demonstrates the immediate arteriolar vasoconstriction 
response to endotoxin followed by the subsequent phases of changing microvascular tone and 
ultimate cardiovascular collapse.(20)(13) 
The release of endotoxin or proinflammatory cytokines initiates a cascade of cellular and 
mediator changes in sepsis. The cornerstone of impaired homeostasis in sepsis is an inflamed 
microcirculation. It is clogged with microthrombi and leaks extensively and  the central role 
in this microcirculatory dysfunction is in turn played by the endothelium. 
  35
 
Activation of the coagulation cascade leading to intravascular thrombosis is also a result of 
the damaged endothelium that starts liberating procoagulant factors. Besides these alterations, 
the endothelium also fails to perform its regulatory functions, and its nitric oxide (NO) 
system is severely disturbed. There is a heterogenous expression of inducible nitric oxide 
synthase (iNOS) in the endothelium of different areas of organ beds.  Areas that lack iNOS 
have less NO induced vasodilation and become underperfused resulting in pathological 
shunting of blood flow.. 
 
                        The endothelium is not the only component of microcirculation to be altered. 
The arterioles are hyporesponsive to vasoconstrictors and vasodilators despite the elevated 
levels of catecholamines[, perfused capillaries are reduced in number, and venules are 
obstructed by the sequestered neutrophils. In the capillaries, besides a decreased density, 
there also occurs increased heterogeneity and an increase in the proportion of stopped and 
intermittently perfused capillaries. 
This shut-down of the vulnerable microcirculatory units in the organ beds promotes the 
shunting of blood and hence oxygen, from arterial to venous compartment leaving the 
microcirculation hypoxic, along with a decrease in oxygen extraction. The local micro-
circulatory partial pressure of oxygen drops below the venous oxygen pressure. This 
difference has been termed the "pO2 gap" and is an indicator of the severity of functional 
shunting . The systemic manifestation of this pathologic shunting is seen as a deficit of 
oxygen extraction by tissues with an apparently normal delivery, and raised venous pO2 , 
lactate, and gastric CO2 , levels. In addition, the blood flow regulation of microcirculation is 
severely disrupted. 
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Assessment of microcirculation 
 
                    Till date, there is no single objective gold standard to assess the microcirculation. 
In clinical practice, microcirculatory perfusion has been traditionally judged by the colour, 
capillary refill and temperature of the distal parts of the body (i.e., finger, toes, earlobes and 
nose). Amongst the investigational modalities available to assess microcirculation, both 
indirect indicators as well as direct techniques exist , even though any single objective 
reliable method is still not recognized. Indirect techniques involve measurement of  
'downstream' global derivatives of microcirculatory dysfunction such as lactate,  
carbondioxide, and venous oxygen saturation. The direct imaging of microcirculatory 
perfusion seems a superior approach to assessment of microcirculation. 
Measurement of serum lactate levels provides a marker of global tissue hypoxia in the host, 
and its prognostic value for predicting survival in shock from various causes in animal 
models and humans has been well established. 
Hemodynamic parameters, usually used to assess the perfusion of organs and tissues, like 
arterial blood pressure, heart rate, urine output and blood gases can be normal in the presence 
of tissue hypoxia and cannot rule out imbalances between global oxygen supply and demand. 
Mixed venous oxygen saturation (SvO2) is a sensitive indicator of the adequacy of whole-
body tissue oxygenation. However, it requires the placement of a pulmonary artery catheter, 
which is an invasive procedure with the possibility of numerous complications and is 
increasingly questioned due to the lack of evidence that it improves outcome. Central venous 
oxygen saturation (ScvO2) requires the insertion of a central venous catheter, which is 
routinely used in most critically ill patients. 
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It can be used as a surrogate for mixed venous oxygen saturation because the changes and 
trends of both variables parallel each other. Both variables are used extensively in the 
treatment of patients with severe sepsis, shock and trauma. In combination with other 
hemodynamic and biochemical parameters, they have diagnostic and prognostic value and 
allow for rational treatment of critically ill patients. 
 
VENOUS OXIMETRY 
Physiology and pathophysiology of venous oxymetry 
Venous oxymetry reflects the balance between oxygen supply or delivery (DO2) and oxygen 
consumption (VO2). DO2 is dependent on cardiac output (CO) and oxygen content in arterial 
blood (CaO2) which is the sum of oxygen bound to haemoglobin product of haemoglobin 
concentration (Hb) and arterial O2 saturation (SaO2)] and physically dissolved oxygen 
(PaO2), according to the following formulas:(21) 
DO2 = CO x CaO2 
CaO2 = (Hb x 1,36 x SaO2) + (PaO2x 0,0031) 
The amount of physically dissolved oxygen is small and can be neglected for practical 
purposes. Thus, oxygen delivery is defined mostly by CO, Hb and SaO2. Clinical conditions 
that can affect DO2 are low cardiac output, anemia and hypoxia (decreased DO2) and high 
cardiac output or CaO2 which increase DO2 .  Oxygen demand or whole-body oxygen 
consumption (VO2) can be expressed by the product of CO and arteriovenous O2 content 
difference (CaO2 – CvO2) which is known as the Fick principle: 
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VO2 = CO x (CaO2 – CvO2) or rearranged 
CvO2 = CaO2 – VO2 / CO 
That means that mixed venous oxygen content (CvO2) reflects the relation between whole 
body oxygen consumption and cardiac output under conditions of constant CaO2. CvO2 can 
also be expressed by the equation: 
CvO2 = (Hb x 1.36 x SvO2) + (PvO2x .,0031) 
As physically dissolved oxygen can be neglected, the principal determinants of CvO2 are Hb 
and SvO2. Since Hb is usually constant in a certain period of time, CvO2 is mostly 
determined by SvO2. SvO2 is inversely related to the VO2 / CO ratio. Clinical conditions 
that can affect VO2 are stress, pain, hyperthermia and shivering  or analgesia, sedation, 
mechanical ventilation and hypothermia which decrease O2 consumption. 
Oxygen delivery and consumption are linked by a simple relationship: 
VO2 = DO2 x ERO2 or 
ERO2 = VO2 / DO2 
where ERO2 represents oxygen extraction ratio as a percentage. Normally ERO2 is about 
25% which means that 25% of delivered oxygen is taken up by tissues and 75% returns to the 
lungs.(22)(18) 
ERO2 is inversely related to SvO2, which is shown in the equation: 
SvO2 = 1 – ERO2 
  39
Therefore, normal ERO2 of 25% corresponds to SvO2 of 75%, and ERO2 of 60 % matches 
SvO2 of 40%. Under normal conditions VO2 is independent of DO2 because tissues can 
meet their needs for oxygen by increasing extraction. When this compensation is exhausted at 
critical DO2, VO2 becomes dependent of DO2. Anaerobic metabolism occurs and lactates 
begin to rise.(23)(24) 
Oxygen delivery and consumption vary during physiological (exercise) and clinical 
conditions. The normal cardiovascular response to increasing VO2 is to increase ERO2 and 
cardiac output. SvO2 normally decreases during exercise because the increased cardiac 
output cannot match completely the increased O2 demand. Therefore, a drop in SvO2 does 
not necessarily mean that tissue hypoxia is occurring but represents increased metabolic 
stress. The extent of the SvO2 drop denotes the magnitude of the stress.  In a healthy person 
anaerobic metabolism usually occurs when SvO2 drops below 40% for a substantial period of 
time. In patients with severe heart disease the ERO2 is increased at rest and they can live with 
SvO2 in the low range without apparent hypoxia because they have adapted to hypoxia 
(rightward shift of oxyhemoglobin dissociation curve ,adaptation of peripheral 
microvasculature). In a septic patient misdistribution of blood flow and the disturbance of 
mitochondrial oxygen utilization may cause anaerobic metabolism in the presence of normal 
or even high SvO2. In that case blood lactate levels and base deficit will be high. 
The normal values of SvO2 are considered to be between 60 and 80%.  Examples from above 
show that SvO2 values should be interpreted carefully in the context of a wider clinical and 
biochemical picture.  
Venous oximetry can reflect the adequacy of tissue oxygenation only if the tissue is still 
capable of extracting O2. In the case of arteriovenous shunting on the microcirculatory level 
or cell death, SvO2 and ScvO2 may not decrease or even show elevated values despite severe 
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tissue hypoxia. As demonstrated in patients after prolonged cardiac arrest, venous hyperoxia 
with an ScvO2 higher than 80% is indicative of impaired oxygen use. 
While measurement of SvO2 requires the insertion of a pulmonary artery catheter, 
measurement of ScvO2 requires only central venous catheterization. ScvO2 directed early 
goal-directed therapy improves survival in patients with septic shock  who are treated in an 
emergency department. However, ScvO2 values may differ from SvO2 values, and this 
difference varies in direction and magnitude with cardiovascular insufficiency. ScvO2 should 
not be used alone in the assessment of the cardiocirculatory system but combined with other 
cardio-circulatory parameters and indicators of organ perfusion such as serum lactate 
concentration and urine output.(25) 
 
 
 
 
Figure 5    Causes for deranged venous oxygen content(SvO2) 
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CLINICAL APPLICATION OF SCVO2(12) 
1. SEVERE SEPSIS AND SEPTIC SHOCK 
Severe sepsis and septic shock are frequently complicated by the development of the multiple 
organ dysfunction syndrome(MODS). Tissue hypoxia is believed to be one of the most 
important mechanisms for the onset of MODS.  
However, treatment concepts favoring the achievement of a maximum O2 delivery have 
proven to be of no benefit in these patients.  Furthermore, it is very difficult to define goals 
for cardiovascular resuscitation in these patients. In this context, Rivers and coworkers 
demonstrated in patients with severe sepsis or septic shock that an early and aggressive 
resuscitation guided by the ScvO2 in addition to central venous pressure and mean arterial 
pressure reduced the 28 day mortality rate from 46.5% to 30.5% (p=0.009) .  
 This concept was called Early Goal Directed Therapy (EGDT).  Compared to the 
conventionally treated group, the EGDT group received more fluids, more frequently 
required dobutamine, and more blood transfusion during the first 6 hours.  
This resulted in a faster and better improvement of organ function in the EGDT group. The 
application of EGDT in the early resuscitation of patients with severe sepsis or septic shock is 
recommended in current guidelines.  In a multi centre study of ScvO2 as a predictor of 
mortality in sepsis done by Pope  etal showed that both the hypoxia and the hyperoxia group 
had significantly higher mortality than the normoxia group.  In multivariate analysis for 
initial ScvO2 the hyperoxia group was associated with increased mortality but not the 
hypoxia group.  Similarly retrospective analysis done in patients with septic shock by julien 
textoris etal suggested that the ScvO2 max was 85% in nonsurvivors compared with 79% in 
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the survivors(p value = 0.009) raising concerns about high levels of ScvO2 in sepsis patients; 
the probable cause being impaired oxygen extraction. 
 
2. SEVERE TRAUMA AND HEMORRHAGIC SHOCK 
The care of severely traumatized patients is defined by early and aggressive resuscitation 
followed by early surgical intervention. Patients with shock, that have been 
haemodynamically stabilized according to vital signs such as heart rate, blood pressure, and 
central venous pressure, had an insufficient ScvO2 in 50% of cases .  
Those patients with a ScvO2 <65% were in need of further intervention and demonstrated 
prolonged cardiac dysfunction and elevated lactate levels. Although there has been no study, 
which investigated the validity of ScvO2 to guide haemodynamic stabilization in 
polytraumatized patients, there is good evidence from patients with severe sepsis or septic 
shock that the ScvO2 is a good parameter in the resuscitation of haemodynamically unstable 
patients.  
 In patients who are initially haemodynamically stable after trauma, a ScvO2 below 65% was 
able to detect those patients who suffered from blood loss and were in need of blood 
transfusion. 
 
 
POLYTRAUMA 
  43
Organ and tissue damages caused by a trauma impact lead to the development of systemic 
inflammatory response syndrome (SIRS).  The local and systemic release of inflammation 
mediators produces oxidative stress, capillary leakage, microcirculatory disturbances, 
metabolic alteration, imbalance of pro- and anti-inflammatory mechanisms, ischaemia or 
reperfusion injury, coagulation disturbances.  In major trauma, occult tissue hypoperfusion 
within the first 24 hours after event precedes multiple organ dysfunction syndrome(MODS). 
Immediate and early trauma deaths are determined by primary brain injuries, or significant 
blood loss (haemorrhagic shock), while late mortality is caused by secondary brain injury and 
host defence failure.(26) 
First hits (hypoxia, hypotension, organ and soft tissue injuries, fractures), as well as second 
hits (e.g. ischaemia or reperfusion injuries, compartment syndromes, operative interventions, 
infections), induce a host defence response. This is characterized by local and systemic 
release of pro-inflammatory cytokines, arachidonic acid metabolites, proteins of the contact 
phase and coagulation systems, complement factors and acute phase proteins, as well as 
hormonal mediators: it is defined as systemic inflammatory response syndrome (SIRS), 
according to clinical parameters.  However, in parallel, anti-inflammatory mediators are 
produced (compensatory anti-inflammatory response syndrome (CARS).  An imbalance of 
these dual immune responses seems to be responsible for organ dysfunction and increased 
susceptibility to infections(27) 
Endothelial cell damage, accumulation of leukocytes, disseminated intravascular coagulation 
(DIC) and microcirculatory disturbances lead finally to apoptosis and necrosis of 
parenchymal cells, with the development of multiple organ dysfunction syndrome (MODS), 
or multiple organ failure (MOF).  Despite the unquestionable usefulness of routinely 
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monitoring of hemodynamic parameters, such as arterial lactate, central venous pressure, 
blood pressure, heart rate, urinary volume, hypoxia may exist despite normal clinical values. 
Continuous monitoring of central venous oxygen saturation (ScvO2) has been proposed as an 
indicator of tissue hypoperfusion. Although the reliability of ScvO2, compared with mixed 
venous oxygen saturation (SvO2), is still under discussion, particularly under shock 
conditions , the prognostic importance of low level (≤ 65%) of ScvO2 has been highlighted in 
severe sepsis , myocardial infarction , cardiac failure , and trauma . Moreover, ScvO2 can be 
easily monitored with a central venous line, whereas SvO2 requires a pulmonary artery 
catheterization. 
No studies have evaluated ScvO2 in patients affected by major trauma so far.  The most 
numerous and extensive studies on ScvO2 optimization have been performed on septic 
patients . The pathogenic changes following major trauma include SIRS, oxidative stress, 
capillary leakage, metabolic alterations, and diffuse tissue hypoxia as a result of circulatory 
abnormalities .  This pathophysiological process is somehow very similar with what observed 
in septic patients, although sepsis presents a different aetiology, evolution and possibility to 
be treated with antibiotics. 
Considering the good evidence in patients with severe sepsis or septic shock, the use of 
ScvO2 to guide hemodynamic optimization in polytraumatized patients would merit to be 
adequately investigated. 
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Host defence response after trauma. 
 
 
 
Figure 6 
APC: antigen presenting cells. TH, T-helper cells (lymphocytes); SIRS, systemic 
inflammatory response syndrome; CARS, compensatory anti-inflammatory response 
syndrome; PMNL, polymorphonuclear leukocytes; MODS, multiple organ dysfunction 
syndrome; MOF, multiple organ failure. 
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Oxidative stress and capillary leakage. 
 
 
 
 
 
Figure 6 
 
 
 
Activated polymorphonuclear leukocytes (PMNL) release reactive oxygen (ROS) and 
reactive nitrogen species (RNS). These metabolites in combination with proteases are 
responsible for endothelial cell damages and the development of a capillary leakage. 
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APACHE II SCORING 
APACHE II – Acute Physiology and Chronic Health Evaluation System is a severity 
of disease classification which was first validated and used by Knaus W A et al and published 
in the Critical Care Medicine Journal in 1985.  APACHE II uses a point score based upon 
initial values of 12 routine physiologic measurements, age, and previous health status to 
provide a general measure of severity of disease.  The physiological measurements include 
the temperature, mean arterial pressure, heart rate, respiratory rate, oxygenation, arterial pH, 
serum sodium levels, serum potassium level, serum creatinine (with or without acute renal 
failure), haematocrit, the total count and the Glasgow Coma Score.(28) 
The score ranges from 0 to 71 with a worsening outcome as the score rises.  When APACHE 
II scores are combined with an accurate description of disease, it can be used to prognosticate 
acutely ill patients and will also guide investigators to compare new modes of treatment. 
Another use of the APACHE II score is that it can be used to evaluate the use of hospital 
resources and compare between intensive care units as to the efficacy of care. 
APACHE II has been used universally in many clinical trials since it provides a consistency 
between different groups. An objective scoring system such as the APACHE II score, allows 
audits of different units or the same unit with historical controls, and comparisons of different 
treatment modalities in those with similar severity of illnesses. In the current environment of 
escalating medical costs the APACHE II scores may allow us to restrict intensive care to 
those most at need, and provide a gauge of illness for deciding how aggressive management 
should be.   The popularity in the use of the APACHE II score is that it is simple to use and 
there is available software to simplify analysis. 
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APACHE II score = (acute physiology score) + (age points) + (chronic health points)(29) 
Acute Physiology Score 
1= Rectal temp (C) 
2 = Mean arterial pressure (mmHg) 
3 = Heart rate (bpm) 
4 = Respiratory rate (bpm) 
5 = Oxygen delivery (ml/min) 
6 = PO2 (mmHg) 
7 = arterial pH 
8 = Serum sodium (mmol/l) 
9 = Serum potassium (mmol/l) 
10 = Serum creatinine (mg/dl) 
11 = Haematocrit (%) 
12 = White cell count (103/ml) 
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 +4 +3 +2 +1 0 +1 +2 +3 +4 
1 >41 39-40.9  38-38.9 36-38.4 34-35.9 32-33.9 30-31.9 <29.9 
2 >160 130-159 110-129  70-109  50-69  <49 
3 >180 140-179 110-139  70-109  55-69 40-54 <39 
4 >50 35-49  25-34 12-24 10-11 6-9  <5 
5 >500 350-499 200-349  < 200     
6     > 70 61-70  55-60 < 55 
7 >7.7 7.6-7.69  7.5-7.59 7.3-7.49  7.25-7.3 7.15-7.2 < 7.15
8 >180 160-179 155-159 150-154 130-149  120-129 111-119 <110 
9 >7 6-6.9  5.5-5.9 3.5-5.4 3-3.4 2.5-2.9  <2.5 
10 >3.5 2-3.4 1.5-1.9  0.6-1.4  <0.6   
11 >60  50-59.9 46-49.9 30-45.9  20-29.9  < 20 
12 >40  20-39.9 15-19.9 3-14.9  1-2.9  < 1 
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Age Points 
Age Points 
<44 0 
45-54 2 
55-64 3 
65-74 5 
>75 6 
 
 
 
Chronic Health Points 
History of severe organ insufficiency Points 
Non-operative patients 5 
Emergency postoperative patients 5 
Elective postoperative patients 2 
 
 
 
Organ insufficiency or immunocompromised state must have preceded the current admission 
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Immunocompromised if: 
• Receiving therapy reducing host defences (immunosuppression, chemotherapy, 
radiation therapy, long term steroid use, high dose steroid therapy) or 
• Has a disease interfering with immune function such as malignant lymphoma or 
leukaemia. 
Hepatic insufficiency if: 
•  Biopsy proven cirrhosis 
• Portal hypertension 
• Episodes of upper GI bleeding due to portal hypertension 
• Prior episodes of hepatic failure, coma or encephalopathy 
Cardiovascular insufficiency if: 
• New York Heart Association Class IV 
Respiratory insufficiency if: 
• Severe exercise restriction due to chronic restrictive, obstructive or vascular disease, 
• Documented chronic hypoxia, hypercapnia, secondary polycythaemia, severe 
pulmonary hypertension 
• Respirator dependency 
Renal insufficiency if:   
• On chronic dialysis 
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PATIENTS AND METHODS 
SETTINGS: 
                The study was done in the Surgical Intensive Care Unit (SICU) of Christian 
Medical College Hospital, Vellore which is a 2000 bedded tertiary care hospital serving about 
90,000 inpatients and 1.5 million outpatients annually.  The study was done among 86 
patients who fulfil the inclusion criterion with a diagnosis of sepsis and or polytrauma from 
May 2011.  They were enrolled in the study after obtaining written consent wherever 
possible. Where this was not possible, an assent would be obtained from the next of the kin in 
a language comprehensible to them.   The protocol received approval from the Institutional 
Review Board of Christian Medical College, Vellore and was funded by the fluid research 
fund of the Christian Medical College. 
 
ELIGIBILITY: 
 Patients between age 18 to 80 years admitted to SICU and SHDU with a diagnosis of sepsis 
and poly trauma. 
 
EXCLUSION CRITERIA: 
 
1. Age less than 18 years or above 80 years 
2. Pregnant mothers 
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3. Known cases of chronic lung disease 
4. Known cases of cardiac disease – moderate to severe left ventricular failure, Intra and 
extra cardiac shunts. 
5. Liver failure – acute / chronic 
6. Patients recruited in another trial 
7. Patients with central venous catheter whose tip is not in the superior vena cava. 
 
The sample size was calculated based on mortality of 30% associated with sepsis and trauma 
from previous studies. 
      P=30% 
      Q=100-30%=70%(power of the study) 
       D2=7x7(+/_5) 
      Sample size =4xpxq/d2 
                          =4x30x70/7x7 
                          =170 
Thus arriving to a sample size of 170.  The study was censored at 86 subjects in order to meet 
the deadline for submission of thesis. 
 
A blood sample from a central venous catheter, whose tip is located in the superior venacava 
was collected after ensuring that the systemic oxygen saturation on the pulse-oximeter is 
more than93 % according to the unit protocol.  Simultaneously, an arterial blood sample was 
obtained for analysis.  A similar set of central venous and arterial sample were collected for 
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analysis 6 hours after ICU admission.  Severity of illness scoring (APACHE II) was recorded 
24 hours after hospital admission.  The patients were subjected to the standard treatment. 
During the treatment period, need and duration of inotropic support, ventilatory support,  
renal replacement therapy were collected in a data sheet by the investigators or the doctors in 
charge.  ICU mortality and 28 day in hospital mortality were recorded. 
 Variables of interest were ScvO2, Blood Lactate and base excess. 
Scvo2 was measured by doing a venous blood gas analysis one at the time of admission to 
SICU and the other after 6 hours and ScvO2 levels were  stratified into the clinically 
meaningful groups of low (ScvO2 0 < 65%), normal (65-75%), and supra-normal (>75%). 
These thresholds were selected apriori. 
Lactate and base excess were measured by doing an arterial blood gas analysis similarly one 
at admission and one after 6 hours .The lactate values of 0.5 to 2.0mmol/l were considered 
normal. 
The base excess of -3 to +3 was considered normal. The three groups namely the low, normal 
and supra-normal SCVO2 were compared.  The oxygen extraction was calculated based on 
the arterial and venous oxygen content which could be calculated with the values obtained in 
the blood gas analysis. 
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STATISTICAL METHODS: 
1) The mortality rate was calculated with 95% confidence interval. 
2) Association between various factors (ScvO2, lactate, base excess) and mortality was 
assessed using chi square tests. 
3) Multivariate logistic regression analysis were performed to identify independent 
predictors of mortality. 
4) ORS with 95% confidence interval was calculated. 
The mortality rates for the respective groups were compared to determine statistical 
significance using Fisher's exact test, with alpha set at 0.017 using a Bonferonni 
correction(0.05/3 = 0.017) to adjust for multiple comparisons. We also performed a 
univariate analysis of the covariates that we collected using fisher's exact test, followed by a 
stepwise logistic regression (both automated and by-hand) retaining significance covariates (p 
< 0.05), to control for confounders in evaluating the relationship between ScvO2 and 
mortality. 
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RESULTS 
A total of 86 patients who met the criteria for ICU admission were enrolled in the study.  
There were almost equal number of patients between 18-45 years and above 45 years with 
mean age of 43.85 (SD16.293) .  32.56% were women and 67.44 were men. 88% were 
admitted with a diagnosis of sepsis and 12% had diagnosis of   poly trauma. The common co-
morbidities were diabetes (17%), hypertension (4%) and chronic kidney disease (5.81%). The 
overall mortality for all patients was 11.63% (10/86 patients). The mean APACHE II score 
was 15.05 with minimum value of 5 and maximum value of 32. 
 
                                      SCVO2 
     HYPOXIA 
       (<60)         
  NORMOXIA 
    (60-75) 
   HYPEROXIA 
       (75.1-100) 
 
GENDER 
MALE 9 29 24 
FEMALE 4 11 9 
 
MORTALITY 
YES 1 3 6 
NO 12 37 27 
AGE (years) MEAN 43 42 55 
APACHE II MEAN 14 14.15 15.934 
 
Table 2- Baseline data 
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The mean SCVO2 at admission was 72.16 with a minimum of 44 and maximum value of 95. 
The plot below depicts the distribution of the SCVO2 values.  
 
Figure.8- Distribution of SCVO2 at admission. 
A similar pattern with mean of 72.2 and minimum value of 45 and maximum of 85 was seen 
6 hours after ICU admission as in fig.9 
 
Figure.9 - Distribution of SCVO2 6 hours after ICU admission. 
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Next we evaluated the mortality related to SCVO2 values at admission to the ICU and to 6 
hours after admission.  At admission 15% had hypoxia (low SCVO2) with a mortality of 
7.69% (1/13) and 46% had normoxia with a mortality of 7.65% (3/40) and 38% had 
hyperoxia (high SCVO2) with a mortality of 18.8% (6/33). After 6 hours of ICU admission, 
the mortality was nil in the hypoxia group, 7.76% in the normoxia group and 22.58% in the 
hyperoxia group. The mean SCVO2 at admission in the alive group was 71.65 (CI of 69.53-
73.76) and in the mortality group was 76.44 (CI of 70.07-82.81).  These values were almost 
same after 6 hours of ICU admission.  Similarly mean APACHE II score in the patients who 
survived was 14.08 and was 22.30 in the patients who did not survive.  
 
 
Figure-10 
Correlation of ScvO2 to mortality at admission 
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Figure -11. Correlation of ScvO2 to mortality after 6 hours 
 
In figure 10 and figure 11 graphically though it shows that hyperoxia group has a higher 
mortality statistically its not significant. 
When compared to the normoxia, the mortality in the hyperoxia group was 2.422 times 
higher though not statistically significant. The hypoxia group had 1.0256 times more likely 
hood of mortality compared to the normoxia group. When the hypoxia group was compared 
with the hyperoxia group the risk ratio for mortality was 2.36 times more in the hyperoxia 
group though the p value was not significant. This is probably due to the reason that only 86 
patients were recruited against the planned 170 due to time constraints and that the study is 
ongoing and the results may become significant when all the patients are recruited. 
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Figure -12. Correlation of APACHE II score and mortality  
Apache ll score as shown in arlier studies shows that it’s a good indicator of mortality when 
the scores are high which is shown in figure 12. 
When oxygen extraction ratio was compared, the hyperoxia group had significantly lower 
oxygen extraction ratio as shown in figure 13 below.  But there when compared them both to 
mortality was no significance. 
 
Figure-13 Correlation of oxygen extraction ratio to ScvO2 
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Next we saw the relation of SCVO2 with duration of ICU stay, need for dialysis, duration of 
inotropic supports and presence of coagulopathy which showed that both the hypoxia and the 
hyperoxia group required a slightly longer duration of inotropes ,more need for dialysis and 
presence of coagulopathy the data was not statistically significant .But when compared for 
the duration of ICU stay it was longer in the normoxia group probably as they had a better 
survival and the other groups had early mortality. 
 
 
 
   
Figure‐14  incidence of coagulopathy with ScvO2 
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Figure-15 Duration of ICU stay and ScvO2 
 
 
     
Figure-16 Correlation of duration of inotropic support to ScvO2 
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Figure-17  ScvO2 and need for dialysis 
 
 
There was no statistically significant relation between the 3 groups of SCV02 when 
compared with APACHE II score, base excess, lactate levels. When lactates, base excess and 
Scv02 were compared to mortality though not significant gave a j shaped curve suggestive 
that mortality is higher both in the hypoxia and the hyperoxia group compared to the 
normoxia group. 
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Figure‐18  ScvO2 and lactates 
 
 
 
Figure‐19  Correlation of lactate levels to mortality 
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Figure‐20   Base excess to mortality 
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DISCUSSION 
A multicentre study by Pope etal in patients with diagnosis of sepsis showed that maximum 
SCVO2 achieved in both hypoxia group and the hyperoxia group was associated with higher 
mortality and a multivariate analysis in the same study showed that hyperoxia was associated 
with increased mortality. Not many studies have been done which prove this association.(1) 
In a large cohort of SICU patients we have found from multivariate modelling that in patients 
with  hyperoxia (SCVO2 >75%) at admission and 6 hours after admission have an increased 
risk of mortality compared to patients who had normoxia and hypoxia. These values highlight 
the potential significance of venous hyperoxia (or impaired oxygen utilisation) in sepsis and 
polytrauma patients. The probable reason for this is that while low SCVO2 may be a marker 
for macrocirculatory failure, high SCVO2 may reflect microcirculatory or mitochondrial 
failure.  So further investigations to study the cause of impaired oxygen utilisation and 
possible interventions to improve this are necessary in these patients. 
Tissue hypoperfusion can be present even in the presence of normal blood pressure and 
adequate cardiac output, a state sometimes called as cryptic shock.  This may be 
maldistribution of blood flow at the microvascular level or related to mitochondrial 
dysfunction in the presence of adequate substrate delivery. The EGDT algorithm focusses on 
increasing systemic oxygen delivery or improving macrocirculation by increasing preload 
with intravenous volume expansion, increasing oxygen carrying capacity with packed red 
cells, increasing oxygen delivery with inotropes and increasing perfusion pressure with 
vasoconstrictors. But though the macrocirculatory failure is corrected, microcirculatory 
failure and mitochondrial failure potentially will result in dysoxia.(11) 
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In a study done by Mikkelsen(30) showed that initial  high serum lactates was associated with 
mortality independent of clinically apparent shock in patients admitted to the emergency 
department with severe sepsis.  Our data though not statistically significant shows higher 
mortality in higher lactate (>2mmols) group. 
Our data also showed that patients with hyperoxia require a slightly longer duration of 
inotropes and higher need for dialysis with more coagulopathy but these were not statistically 
significant. Though mean duration of ICU stay was less in the hyperoxia group, this probably 
was because these patients died earlier. Also there was lower oxygen extraction ratio with 
higher mortality in hyperoxia group. This supports the concept of cellular hypoxia due to 
microcirculatory and mitochondrial failure despite adequate augmentation of 
macrocirculatory failure. The clinical relevance of mitochondrial dysfunction in septic shock 
was suggested by a study of 28 critically ill septic patients who underwent skeletal muscle 
biopsy within 24 hours of admission to the ICU. Skeletal muscle ATP concentrations, a 
marker of mitochondrial oxidative phosphorylation, were significantly lower in the 12 
patients who died of sepsis than in 16 survivors.  Thus, cell injury and death in sepsis may be 
explained by cytopathic (or histotoxic) anoxia, which is an inability to utilize delivered 
oxygen. The microcirculation (i.e., capillaries) may be the most important target in sepsis. 
Sepsis is associated with a decrease in the number of functional capillaries due to shunts. It is 
also associated with microthrombi and the blood flow is sluggish.(10) 
At the level of the endothelium, sepsis induces phenotypic changes to endothelial cells. This 
occurs through direct and indirect interactions between the endothelial cells and components 
of the bacterial wall. In these situations, hyperlactemia indicates on-going tissue 
hypoperfusion due to misdistribution of flow in the microcirculation even after resuscitation 
and normalization of the macrocirculation. This shut-down of the vulnerable microcirculatory 
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units in the organ beds promotes the shunting of blood and hence oxygen, from arterial to 
venous compartment leaving the microcirculation hypoxic, along with a decrease in oxygen 
extraction. The local micro-circulatory partial pressure of oxygen drops below the venous 
oxygen pressure. This difference has been termed the "pO2 gap" and is an indicator of the 
severity of functional shunting . The systemic manifestation of this pathologic shunting is 
seen as a deficit of oxygen extraction by tissues with an apparently normal delivery, and 
raised venous pO2, lactate, and gastric CO2, levels. Thus even with adequate 
macrocirculatory flow, the microcirculatory failure may prevent needed  and available 
oxygen from reaching the cells in vital organs.(1)(31) 
Hence we need further resuscitation protocol to assess microcirculatory failure and use 
therapies to improve microcirculation. We need to look at other markers of mitochondrial 
dysfunction as well as therapeutic approaches targeting these deficiencies. The finding that 
high scvo2 was associated with increased mortality reminds us that dysoxia can occur despite 
adequate global oxygen delivery and that these abnormalities provide a target for further 
research. 
This study is ongoing to complete the planned recruitment of 170 and the results may become 
statistically significant. 
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CONCLUSIONS 
This cohort study of sepsis and poly trauma patients admitted to Surgical ICU examined the 
relationship between scvo2 and the outcomes of ICU stay. 
1. When compared to the normal group hyperoxia had a risk ratio 2.422 times more likely hood 
of mortality and the hypoxia group had 1.0256  times more likely hood of mortality .When 
the hypoxia group was compared with the hyperoxia group the risk ratio for mortality was 
2.36 times more in the hyperoxia group though the p value was not significant . 
 
2. When lactates, base excess and Scv02 were compared to mortality though not significant 
gave a j shaped curve suggestive that mortality is higher both in the hypoxia and the 
hyperoxia group compared to the normoxia group. 
 
3. When compared with oxygen extraction ratio those with hyperoxia had significantly lower 
oxygen extraction but no significant relation to icu mortality. 
 
4. People with a mean apache 11 score of 22 had a significantly higher mortality, but in no 
relation to scvo2. 
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LIMITATIONS 
1. The small sample size though was adequate to predict a trend, was insufficient to address 
secondary objectives. 
 
2. Few cases were initially resuscitated in the emergency department and later shifted to the 
intensive care unit which would have affected the initial Scvo2 values. 
 
3. The number of cases of polytrauma were a meagre 12 % of the total sample size and 
therefore is difficult to comment on any particular trend. 
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ANNEXURE 
1. figure 1  Potential outcomes of mediator release in sepsis. 
2. figure 2  Decreased oxygen extraction in sepsis. 
3. figure 3  Oxygen transport. 
4. figure 4  Early goal directed therapy(EGDT). 
5. figure 5  Causes for deranged venous oxygen content(SvO2). 
6. figure 6  Host defence response after trauma. 
7. figure 7  Oxidative stress and capillary leakage. 
8. figure 8  Distribution of SCVO2 at admission. 
9. figure 9  Distribution of SCVO2 6 hours after ICU admission. 
10. figure 10  Correlation of ScvO2 to mortality at admission. 
11. figure 11  Correlation of ScvO2 to mortality after 6 hours. 
12. figure 12  Correlation of APACHE II score and mortality. 
13. figure 13  Correlation of oxygen extraction ratio to ScvO2. 
14. figure 14  incidence of coagulopathy with ScvO2. 
15. figure 15  Duration of ICU stay and ScvO2. 
16. figure 16  Correlation of duration of inotropic support to ScvO2. 
17. figure 17  ScvO2 and need for dialysis. 
18. figure 18  ScvO2 and lactates. 
19. figure 19  Correlation of lactate levels to mortality. 
20. figure 20  Base excess to mortality. 
21. Table 1  Biologic efects of proinflammatory cytokines such as TNF and IL-1(8). 
22. Table 2  Baseline data. 
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STUDY TOOLS 
 
 
PATIENT INFORMATION SHEET 
 
The department of Surgical Intensive care CMC Vellore is conducting a study to assess the 
impact of oxygen levels in the blood and blood lactate on the outcome in patients with 
diagnosis of sepsis and trauma. 
If you/your relative agrees to participate in this study we will be collecting four blood 
samples (about 4 milliliters in total). The blood will be analysed and other information with 
regard to blood pressure and supportive care like ventilation will be recorded. There won’t be 
any new changes in the treatment based on the results other than the standard changes we 
normally do. You / your relative will not have to pay extra anything for the tests or treatment. 
Your / your relative’s condition will be assessed by the respective ICU team on a daily basis 
and the normal treatment will continue. 
Your participation in the study is entirely voluntary and you are free to withdraw from the 
study at any point of time during the course of the study. Withdrawal from the study will not 
affect the treatment. The results from the blood tests and the other details related to heart, 
lungs and kidneys will be used for analysis. We will ensure that full confidentiality is 
maintained. 
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INFORMED CONSENT 
 
 
Study Title: A prospective observational study to characterize the association of abnormal 
central venous oxygen saturation to the morbidity and mortality in patients admitted to the 
Intensive Care unit with a diagnosis of sepsis or trauma. 
 
Subject’s Initials: _________  Subject’s Name: ________ 
Date of Birth / Age:_______ 
Please initial box  
(Subject) 
(i) I confirm that I have read and understood the information sheet dated _________ for the 
above study and have had the opportunity to ask questions. [ ] 
(ii) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my medical care or legal 
rights being affected. [ ] 
 (iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor’s 
behalf, the Ethics Committee and the regulatory authorities will not need my permission to 
look at my health records both in respect of the current study and any further research that 
may be conducted in relation to it, even if I withdraw from the trial. I agree to this access. 
However, I understand that my identity will not be revealed in any information released to 
third parties or published. [ ] 
(iv) I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purpose(s) [ ] 
(v) I agree to take part in the above study. [ ] 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
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Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
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DATA SHEET 
Demographic data of patients coming to SICU with trauma or sepsis. 
 
1. Age [years]  
 
2. Sex [no. of patients] female/male  
 
3. Body mass index [kg m-2]  
 
4. Co morbidities 
 
5. Chronic medication 
 
6. APACHE II Score 24 hours after admission 
 
7. Hemoglobin level      
             At admission 
             After 6 hours 
 
8. Transfusion requirements  
9. Central venous oxygen saturation  
              At admission 
              After 6 hours 
 
10.  Lactate [mmol/l]     
               At admission 
               After 6 hours 
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   11.      Base excess 
                At admission 
                After 6 hours 
 
   12.     Vital parameters 
 
               a. Heart rate     
                At admission 
                After 6 hours 
 
               b. Blood pressure 
                 At admission 
                 After 6 hours 
 
      c. Respiratory rate 
             At admission 
             After 6 hours 
 
      d. Oxygen saturation 
               At admission 
               After 6 hours 
 
13.   Duration of icu stay 
 
14.   Duration of ventilation 
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15.   Duration of inotropic support 
 
16.    Need for dialysis 
 
17.    ICU mortality 
 
18.    28 day hospital mortality 
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